Biocytogen Pharmaceuticals (Beijing) Co (FRA:I54) Other Long Term Assets : €31.6 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co Other Long Term Assets?

Biocytogen Pharmaceuticals (Beijing) Co's other long-term assets for the quarter that ended in Jun. 2024 was €31.6 Mil.

Biocytogen Pharmaceuticals (Beijing) Co's quarterly other long-term assets declined from Jun. 2023 (€31.9 Mil) to Dec. 2023 (€31.8 Mil) but then stayed the same from Dec. 2023 (€31.8 Mil) to Jun. 2024 (€31.6 Mil).

Biocytogen Pharmaceuticals (Beijing) Co's annual other long-term assets increased from Dec. 2021 (€4.4 Mil) to Dec. 2022 (€34.0 Mil) but then declined from Dec. 2022 (€34.0 Mil) to Dec. 2023 (€31.8 Mil).

Biocytogen Pharmaceuticals (Beijing) Co Other Long Term Assets Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co Other Long Term Assets Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

5.14

4.38

33.96

31.77

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial			4.85	33.96	31.93	31.77	31.60

Biocytogen Pharmaceuticals (Beijing) Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biocytogen Pharmaceuticals (Beijing) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (FRA:I54) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

02315:Hong Kong

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma, and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC), and other solid tumors.

Biocytogen Pharmaceuticals (Beijing) Co Headlines

No Headlines